Abbott (ABT) Tops Q3 EPS by 47c, Sales Beat

Abbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.

GUIDANCE:

Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
• UnitedHealth Group (UNH) Tops Q2 EPS by $1.53, Beats on Revenue; Offers FY26 EPS Guidance
• Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Revenue Beat